Structural insights into chromatin modifiers and remodeles

Patrick Schultz

IGBMC, UMR 7104 CNRS, U1258 INSERM, Université de Strasbourg

Changqing Li, Ekaterina Smirnova, Charlotte Schnitzler, Corinne Crucifix, Arnaud Poterszman, Patrick Schultz, Gabor Papaiand Adam Ben-Shem, in collaboration with Jean Paul Concordet (Museum National d’Histoire Naturelle, U 1154 Inserm, UMR 7196 CNRS)

Chromatin structure is a key regulator of DNA transcription, replication, and repair. In humans, the TIP60/EP400 complex (TIP60-C) is a 20-subunit assembly that impacts chromatin structure via two enzymatic activities: ATP-dependent exchange of histone H2A/H2B for H2A.Z/H2B and histone acetylation, which in yeast are carried out by two independent complexes, SWR1 and NuA4, respectively. How these activities are merged in humans into one super-complex and what this association entails for their structure, mechanism and recruitment to chromatin is unknown. We determined the 2.4 Å resolution cryo-EM structure of the endogenous human TIP60-C. We find a three lobed architecture composed of SWR1-like (SWR1L) and NuA4-like (NuA4L) parts, that associate with a TRRAP activator-binding module. The huge EP400 subunit is exceptionally spread-out, harbors the ATPase motor, traverses twice the junction between SWR1L and NuA4L, and constitutes the scaffold of the three-lobed architecture. NuA4L is completely re-arranged compared to its yeast counterpart and establishes a novel interaction hub. TRRAP is flexibly tethered to this hub, in stark contrast to its robust connection to the complete opposite side of yeast NuA4. A fixed actin module, as opposed to the mobile actin subcomplex in SWR1, the flexibility of TRRAP and the weak effect of extra-nucleosomal DNA on exchange activity, lead to a different, activator-based, mode of enlisting TIP60-C to chromatin. The merging of two enzymatic complexes into one super-assembly leads to far reaching structural adaptations that alter their mechanism of action, target specificity, and recruitment to chromatin.

Comments are closed.